Fig. 6

Summary of results. Colours of the antibodies indicate diversity in antigenic targets, and structures indicate diversity in the isotype usage. A broad baseline profile (left) is favourable for early response, but has no association with long-term outcomes like drug-free remission, as compared to a less broad baseline profile (right). The association with the breadth of the baseline profile diminishes with time